|
30 Years International Conferences
on
Health Effects of Incorporated Radionuclides
Thirty-four years ago, in July 1974, a group of 38 scientists met at the Alta Lodge in Utah, USA, following an invitation from Charles William (Chuck) Mays to discuss the results of the follow-up studies of the 224Radium and Thorotrast patients. This was the first of a series of nine international conferences on the health effects of incorporated alpha-emitting radionuclides. The following lists the past conferences and their associated proceedings publications.
1974, 21-23 July, Alta Lodge, Utah
Biological Effects of 224-Ra and Thorotrast
(Health Phys. 35, 1, 1978)
1976, 20-21 September, Neuherberg (GSF)
Biological Effects of 224-Ra - Benefit and Risk of Therapeutic Application
(Martinus Nijhoff Medical Division - The Hague/Boston 1978 for CEC)
1977, 28 June-2 July, Lisbon
Toxicity of Thorotrast and Other Alpha-emitting Heavy Elements
(Environ. Res. 18, 1, 1979)
1981, 11-16 October, Lake Geneva, Wisconsin
Radiobiology of Radium and the Actinides in Man
(Health Phys. 44, Supplement, 1983)
1984, 29-31 October 1984, Neuherberg (GSF)
The Radiobiology of Radium and Thorotrast
(Urban & Schwarzenberg München-Wien-Baltimore 1986,
Supplements to Strahlentherapie Vol. 80)
1988, 3-5 October, Bethesda, Maryland (NCI)
Risks from Radium and Thorotrast
(BIR Report 21, 1989)
1994, 18-21 April, Heidelberg (DKFZ)
Health Effects of Internally Deposited Radionuclides:
Emphasis on Radium and Thorium
(World Scientific Singapore-NewJersey-London-HongKong 1995)
1999, 19-23 January, Tokyo (University of Tokyo)
Health Effects of Thorotrast, Radium, Radon and Other Alpha-Emitters
(Radiation Research 152, 6, Supplement 1999)
2004, 29 November – 1 December, Neuherberg (GSF – National Research Center for Environmental Health)
Health Effects of Incorporated Radionuclides. Emphasis on Radium, Thorium, Uranium and their Daughter Products
(GSF – National Research Center for Environmental Health)
In order to provide some additional information, extracts from the introductions, forwords and prefaces to these conferences are added on the following pages which reflect the scope and results of these meetings.

Alta, Utah 1974
The symposium was attended by 38 scientists from 7 countries: Austria (1), Belgium (1), England (3), France (1), Germany (6), Portugal (1) and the U.S.A.
From the introduction (Charles W. Mays)
The major objective of the symposium was to assemble human data on bone cancer induced 224-Ra and liver cancers induced by Thorotrast, so that the risk to these organs from 239-Pu could be estimated.
Some highlights of the 16 papers are as follows:
224-Ra is a short-lived isotope of radium with a half-life of 3.62 days. It decays by emission of a-particles to form shorter-lived daughters, which emit alpha-particles or beta-particles. Injected 224-Ra has been used in the therapy of several thousand German patients having bone tuberculosis or ankylosing spondylitis. It is still being used for the treatment of spondylitic patients in Germany and France. Radiochemically pure 224-Ra, which is remarkably free of long-lived contaminants, is routinely prepared for clinical use by the Amersham-Buchler Company of Braunschweig, Germany. Two main follow-up studies are in progress in Germany, each involving about 1000 patients. The older study, started in 1948 by Professor Heinz Spiess, contains most of the high-dose 224-Ra patients and nearly all of the injected children. In the Spiess series, 54 cases of bone sarcoma have occurred. In the newer study, started in 1971 by Professor Otto Hug and Dr. Fritz Schales, one case of reticulum cell sarcoma of bone marrow has been reported, but most of these patients are at low dose and many have short follow-up times.
Extensive and well controlled experiments with 224-Ra in mice confirm the "protraction enhancement effect" for 224-Ra observed in humans. For a given total dose, the effect increases as the period of irradiation is protracted. This effect for densely ionizing alpha-particles from 224-Ra is opposite to that usually observed with sparsely ionizing X-rays, gamma-rays and beta-particles. Injected 224-Ra decays to a large extent on bone surfaces, giving a local distribution of alpha-particle dose somewhat similar to that from 239-Pu. 224-Ra. has caused tooth loss, growth retardation, benign exostoses, and malignant bone sarcomas.
Thorotrast is colloidal 232-ThO2. It was injected as an X-ray contrast medium from 1928 until 1955. When injected into the blood stream, it aggregates primarily in the liver and the spleen. However, some of its daughter products, including 224-Ra, are released and redeposit in bone. For the typical intravascular injection of 25 ml. Thorotrast into a 70-kg adult, the average dose rate to the liver is about 25 rad per yr, while the average endosteal dose rate is (a) about 7 rad per yr from 224-Ra, 228-Th, and 228-Ra translocated from Thorotrast to calcified bone, and (b) an additional 9 rad per yr from Thorotrast on bone surfaces and in red marrow. The most dramatic effect of Thorotrast has been the induction of liver cancer. Among the 3921 European Thorotrast cases under study, 245 have died from liver cancer, an incidence of 6%. For an average liver dose of about 600 rad, the risk coefficient is about 100 liver cancers per 106 person-rad from this liver-seeking alpha-particle emitter (Thorotrast). Among the traced Thorotrast patients, three confirmed and three possible bone sarcomas have been reported, whereas only about 0.5 case would be expected naturally.
Among the 1572 U.S. dial painters and other persons of known dose from long-lived 226-Ra and 228-Ra, 54 bone sarcomas and 26 carcinomas of the sinuses have occurred. The head carcinomas seem primarily due to the accumulation of 222-Rn (radon gas) in the head sinuses, since none have been reported in the 224-Ra and Thorotrast patients, in which the decay scheme does not include 222-Rn.
The risk from 224-Ra and Thorotrast is compared to that from other radiations. The follow-up of irradiated persons is essential to proper evaluation of the risk to man from ionizing radiation.
Did any new general principles emerge during the Symposium? Yes! They are Dudley's first and second laws:
(1) Nothing seems impossible to the person who doesn't have to do the work.
(2) Real science is untidy.


Neuherberg (GSF) 1976
The symposium was attended by 33 scientists.
From the opening address (Wolfgang Gössner)
The first symposium on the biological effects of 224-Radium or Thorium-X was held two years ago at the Alta Lodge in Utah. We all remember a very successful and also enjoyable meeting organized by Professor Mays with a most perfect organization and a homely atmosphere at the same time.
A great part of this meeting was in addition devoted to the problems of Thorotrast. The papers and discussions of this symposium have been concentrated on the description and analysis of the late effects specially bone tumors induced by incorporation of these alpha-emitters and on the problems of dosimetry and radiobiology.
Already during the discussions which we had in preparing this first symposium and again during the Alta-meeting we felt that it would be very important to deal together with clinicians in more detail with the usage of 224-Radium in radiotherapy because this treatment of certain diseases of the skeletal system, mainly ankylosing spondylitis has been retained in some clinical centers up to now.
Therefore the main topic of this symposium will be the discussion and analysis of benefit and risk of the therapeutic application of 224-Radium in the treatment of ankylosing spondylitis and arthritic diseases.
We all are anxious to learn from the findings and experience of the clinicians and they will certainly also profit from the basic findings of the radiobiologists and experimental pathologists. So I believe that the main purpose of this symposium is to bring these two groups together.
We hope that after these two days we will have a more clear picture about the therapeutic effect of 224-Radium in these diseases and also an answer to the question whether this kind of treatment is justified or not.

Lisbon 1977
The International Meeting was attended by 32 scientists.
From the lntroduction and Welcome (Jorge da Silva Horta)
I sincerely hope that this Meeting will prove to be another step forward in the path of research towards a wider understanding of the alterations caused by ionizing actions. I also hope that the present stage of our line of research may in consequence be reinforced and that through the exchange of our ideas, new channels will be pursued. I feel confident that in an ever increasing spirit of solidarity, and with the vast knowledge already acquired on the use of Thorotrast, new information regarding positive or probable lesions, caused by employment of other alpha-emitters, may be discovered.
Nowadays, in a world where such different ideologies prevail, mankind lives in constant alarm. The fear of war looms in front of us, as if the constant so-called "little wars" were the premonition of a larger and devastating one.
But contacts among scientists, especially between those that explore the specialized field of knowledge that studies the consequences of atomic energy, will eventually result in a great and better understanding of all men faced by a common enemy.
I would like to end by quoting Amold Toynbee's words:
"We are living in an age in which, for the first time, the whole human face, over the whole surface of our planet, is growing together in a single-world society. We have, indeed, to become a single-world family. In the atomic age, this is the only way of banishing the present danger that we may commit mass-suicide.
"It is because of the knowledge we have obtained in the field of our research that, better than most, we understand the need for an approach towards a "single-world family."
"However, even if this aim seems no more than a dream, we must always bear in mind the superior meaning of human fraternity. It is in this spirit that we work in our laboratories and that we are here today, and not only for the pleasure of discovering the unknown."
We must bear all this in mind as we now initiate our Meeting.
.gif)
Lake Geneva, Wisconsin 1981
The International Conference was attended by more than 60 scientists.
From the Foreword (J Rundo, Patricia Failla, Robert A. Schlenker)
This volume contains 60 of the papers presented at the International Conference on the Radiobiology of Radium and the Actinides in Man. These contributions constitute more than 75% of the presentations, making the use of the word "proceedings" a reasonable approximation.
By the time the meeting was held, a total of 81 titles appeared in the program, although some were withdrawn at the last minute. After the conference, manuscripts and promises began to arrive in quantity and our best estimate of the number of printed pages swelled to more than 600. This was far more than could be accommodated in a single issue of Health Physics, the average contents of which extend only to 150 pages. At some point in the discussion as to how to resolve the conflict between the projected size and the commitments to authors, the idea of a special supplement to the Journal was mooted, developed and eventually approved by the Board of Directors of the Health Physics Society, with the understanding that it would be distributed at no extra cost to all recipients of the Journal. At the time of conception of the idea of a supplement the refereeing process was almost complete and it was pursued, resulting in the probable twin precedents.
The usefulness of the proceedings of any conference decreases rather rapidly with time and considerably more than a year will have elapsed between the oral presentations and their appearance in print. Authors, reviewers and editors must all accept their share of responsibility for the delay, but we refrain from apportioning it quantitatively!
There is a happy coincidence in the appearance of this volume in 1983; Dr. Harrison S. Martland, the leading light in the elaboration of radium toxicity, was born on 10 September 1883. Some of Martland's papers would be entirely appropriate in these proceedings (e.g. Ma29); had the meeting been held in 1983 the organizers could have had the pleasure of calling it the Harrison S. Martland Centennial Conference.
REFERENCE
Ma29 Martland H. S. and Humphries R. E., 1929, "Osteogenic Sarcoma in Dial Painters Using Luminous Paint", Arch. Path. 7, 406.

Neuherberg (GSF) 1984
The Syposium was attended by 122 scientists.
From the Preface (W.Gössner, G.B. Gerber, U. Hagen, A. Luz)
Two radionuclides, radium and thorium have since long been noted for their deleterious effects to man. About 60 years ago, it had been first reported that dial workers using radium-226 can suffer from "radiumjaw". Cancer of the bone, the mastoids and the nasal sinuses as weIl as non-stochastic alterations have since been described in these persons. Another radium isotope, radium-224, was used for medical reasons during the years around World War II and has given rise to bone cancer as well as to non-cancerous legions.
Thorotrast, a thorium dioxide prepara-tion, introduced for angiography in 1929 and utilized until about 1950, was found to cause liver cancer, liver cirrhosis and myelo-proliferative disorders. Epidemiological data supported by experimental studies are presently thought to provide the best estimate to assess risks not only from these radionuclides but also from other related bone seekers, including actinides. For these reasons, the Radiation Protection Programme of the Commission of the European Communities has initiated and supported studies dealing with the epidemiology of exposed populations as well as with investigations emphasizing basic research in this field.
Indeed, the close relationship of experimental studies and observations in man has characteristically led to the rapid progress made in this field and has greatly aided the feasibility of extrapolation to other conditions. Considerable progress has been made in the meantime, and the present proceedings contain much new material:
The earlier observations in man have been completed and now include information on lower doses of radium-224 and on the appearance of non-stochastic damage such as cataract, tooth breakage and bone changes.
A detailed up-to-date review of the German thorotrast study is summarized and compared with similar data from Danmark and Japan. Interesting differences have been noted between these countries with respect to normal and thorotrast-induced incidence of liver cirrhosis and liver cancer. Dosimetric and experimental studies complement these data.
It is hoped that the information contained in these proceedings will be useful not only for the persons interested in radiation protection but also for radiologists, clinicians and for those scientists working on metabolism of bone and liver.

Bethesda, Maryland (NCI) 1988
This Workshop was attended by 57 scientists.
From the Preface (D. M. Taylor, C. W. Mays, G. B. Gerber and R. G. Thomas)
During the First and Second World War, several thousand persons, mainly young women, were employed in the United States and the United Kingdom on painting luminous watch and aircraft instrument dials. As a result, they ingested considerable quantities of radium-226 or -228.
From about 1930 to 1955, colloidal thorium dioxide (ThO2, Thorotrast) was used quite widely in several countries as a radiographic contrast medium, particularly for angiography. Then in the 1940s and early 1950s, radium-224 was used in the treatment of bone tuberculosis and ankylosing spondylitis in Germany. Sadly, people in all three of these groups have suffered serious ill-effects, especially the development of bone cancer from the radium isotopes and liver cancers from Thorotrast. In the last 30 years it has become increasingly recognized that the study of the long-term effects on the health of these people who were exposed to alpha-particle irradiation from radionuclides deposited in their bones, liver or other organs, is an extremely valuable and unique source of information on the biological effects of such irradiation in humans. Major efforts have been made in Germany, Denmark, Portugal, the United States, Japan and other countries to study these various groups of people.
This volume presents the proceedings of the latest of these meetings, which was held at Bethesda, Maryland, USA, under the joint sponsorship of the US National Cancer Institute, the Radiation Protection Programme of the Commission of the European Communities and the US Department of Energy.
More than 30 papers, discussing human and experimental investigations, were presented by authors from the United States, United Kingdom, East and West Germany, Japan and Denmark. These served not only to update the information on the induction of cancer in bone, liver and other tissues, but also emphasized the importance of considering non-cancerous effects, such as cataract, bone marrow damage and impairment of host defence mechanisms.
They also served to emphasize how much more valuable information is potentially available from these studies, both by the application of the latest molecular biological methods to the analysis of the pathological material which is already available, or which will become available in the future, and by closer international collaboration, such as by acting on Dr John Boice's suggestion of combining the results from the US and the UK radium dial-painter studies, and also the German, Danish and Japanese Thorotrast studies. The workshop brought forth new information and spawned new ideas for future work.
We hope that this information will prove valuable not only to those concerned with radiation biology, radiation protection and risk assessment, but also to those interested in the fundamental mechanisms of the induction of cancer and other diseases by high linear energy transfer radiation.

Heidelberg (DKFZ) 1994
This International Seminar was attended by 85 scientists.
From the Editorial (G. van Kaick, A. Karaoglou, A.M. Kellerer, M. Frazier)
The motivation for these meetings arises from the scientific challenge caused primarily by on-going epidemiological cohort studies evaluating the late effects of human beings in three continents. During the six-year interval between the last meeting and this Seminar new molecular biological techniques for the investigation of cancers have developed so that the Seminar offered a timely opportunity to review the current state of knowledge of the induction of cancer in humans by internally deposited radionuclides. Moreover, the topics considered at this meeting were broadened to radionuclides other than Radium and Thorium, such as Polonium, Plutonium, Americium, and Strontium. The use of epidemiological data for radiation protection requirements is dependent on a knowledge of the accumulated dose to the target cells. There is a large uncertainty in the identification of the target cells, the distribution in and elimination of the radionuclides from the body and therefore the dose to the target cells. Therefore, biophysical measurements, calculations, and animal experiments are crucial for the understanding of the human data. Bearing this in mind more emphasis was given at this Seminar to creating a bridge between epidemiology, molecular biology, cancer genetics and low-dose effects.
It was interesting to see that retired international scientists continue to work in the field and are highly concerned about the continuation of the ongoing studies and the reactivation of studies which have lapsed. Another remarkable experience was that enthusiastic young scientists with new ideas were eager to become involved with this international group of scientists and participate in studies already running for many years. We were happy to hear that the Swedish, Portuguese, Japanese and American Thorotrast studies will be reactivated.
On the other hand during the meeting it became clear that in the human studies the pathohistological results of neoplastic diseases need to be revised critically.
A standardisation of the histological and epidemiological evaluation of the data is absolutely necessary for pooling of the data of the different studies in the near future. For example in Europe the data of 4000 to 5000 Thorotrast patients could be pooled and analysed, thus providing a strong and reliable statistic power of the results.
Science alone is not able to create and organise scientific meetings. Human relationships, friendships over long time periods and long distances and the willingness to do the work of organisation as well as obtaining financial sponsorship are basic requirements for a meeting. It is a great pleasure for us to thank all participants who contributed to the scientific quality of the meeting and to the climate of international friendship. We hope that this seminar gave new perspectives for future research in Health Effects of Internally Deposited Radionuclides.

Tokyo 1999
This International Workshop was attended by 73 scientists.
From the Preface (R. Machinami, Y. Ishikawa and B. B. Boecker)
This meeting in Japan was the first international conference on radium and Thorotrast staged outside of the USA and Europe. The aim was to draw together leading scientists from various regions of the world and from many disciplines, including epidemiology, cancer research, animal studies, dosimetry, pathology, molecular biology, and risk assessment. Discussion was focussed on the health effects and risks from long-term exposure to alpha particles emitted not only by radium and thorium (Thorotrast) but also by other internally deposited radionuclides. Following the last workshop held in Heidelberg, new epidemiological results from Sweden and Portugal were presented.
A series of papers concerning radon exposure at the Wismut mine should provide important new information on radon toxicology. New and revised approaches to the dosimetry of internally deposited radionuclides were also presented. Particular emphasis was put on molecular biology in this workshop. Progress in the methodology of biological research, including use of archival tissues, has revealed new aspects of genetic changes induced by alpha particles. Evidence for the presence of a threshold in bone tumour induction in radium dial painters also fascinated much attention. Collectively, these results demonstrate the value of continuing these workshops to gain a better understanding of the health effects of alpha-particle emitters.
Japan was one of the countries where thorium dioxide was first used for radiography (M. Oka, Fortschr. Roentgenstr. 40, 497-501, 1929). Thereafter, thorium dioxide colloidal agents imported from Germany, largely Thorotrast, were widely used in Japan. However, only several thousand people are estimated to have lived more than 3 years after Thorotrast injection in Japan because most of the injected persons were soldiers. This, in turn, makes the Japanese cohort especially important due to the absence of underlying disorders except war injuries. Epidemiological studies of Thorotrast in Japan were initiated, promoted and conducted with the tremendous efforts of Dr. Takesaburo Mori.
The first results of the Japanese study were presented in 1965 at the first international conference on biological effects of Thorotrast by Dr. Kenpo Tsukamoto, the Director of the National Institute of Radiological Sciences. This presentation included dosimetric data of Dr. Yoshio Kato. Since then, Dr. Mori has been following this cohort, collecting autopsy cases and collaborating with numerous physicians and scientists in a variety of areas for more than 35 years. Also we are very pleased to include a paper in this volume, prepared by Dr. Hiroshi Tanooka, that summarizes the results of data from both Mori's series and another group of Thorotrast patients known as the Aichi series followed by Dr. Choichiro Kido and his colleagues.
As Prof. Wataru Mori mentioned at the beginning of workshop, the year 1998 was the centennial anniversary of the discovery of radium by Marie Curie, whose pioneering work stimulated physics and medicine being united into radiology. It was particularly appropriate that such an interdisciplinary conference was one of the activities of the Centennial of the Discovery of Radium Project in Japan.
Periodical workshops tend to draw the same people just like alumni meetings. In this workshop in Tokyo, however, many young scientists attending for the first time were involved in active and stimulating discussion. Certainly we hope that these young scientists will continue to be productive and creative participants in these important research areas. We look forward to meeting together in the future.
.gif)
Neuherberg (GSF) 2004
The Conference was attended by 158 scientists from 21 countries.
From the Introduction
(H.G. Paretzke, P. Roth, U. Oeh)
The ninth international conference on “Health Effects of Incorporated Radionuclides – Emphasis on Radium, Thorium, Uranium and their Daughter Products” HEIR 2004 was held at GSF–National Research Center for Environment and Health, Neuherberg, Germany, from November 29 until December 1, 2004.
The growing popularity of this topic among the scientific community, especially the radiation protection community, was demonstrated by the largest number of participants in comparison to the earlier conferences. In all, there were 157 participants from 20 different countries of the world. In the conference 62 scientific and 12 posters presentations were included in 13 sessions. The scope of the conference covered studies related to the long-term follow-up of thorotrast subjects in Japan, Germany and Portugal, and also of the subjects exposed to Ra-224 for the treatment of bone tuberculosis and ankylosing spondylitis. The studies and discussions on these topics are important in view of the large number of liver cancers observed in the thorotrast patients and the number of bone cancers in the cases treated with Ra-224. A growth stunting was also observed for the subjects who received the Ra-224 injections early in their lives. Besides atom bomb survivors, the data from thorotrast patients could well help towards a better understanding of the health effects of irradiations.
In addition to the scientific presentations on the above topics, there were a number of presentations on the incidence of lung cancer from radon exposure of miners and plutonium exposures causing lung cancer among the Mayak workers in the Russian Federation.
Other stimulating presentations were on the tissue damaging mechanisms of alpha particles, having very high L.E.T., and also the related radiation weighting factor in comparison to beta and gamma radiations. There were also interesting presentations on the topics of uncertainties involved in the internal dose assessment from radiation exposure and the possible solutions to minimize the errors due to uncertainties and make radiation protection more effective.
Also discussed were the main challenges and problems encountered in radiation protection regarding the possible questions posed and the decisions needed to be taken in understanding processes such as the 1) tumour induction from external and internal exposures, 2) prediction of risk for the ingestion from long-lived radionuclides and 3) whether a chronic exposure is equivalent to the sum of acute exposures. There were also a few, but very important presentations on the development and applications of highly sensitive analytical techniques for measuring Th, U and Pu in biological matrices such as body fluids.
A couple of papers were presented on the current challenges of the twenty-first century to assess the exposure of humans to depleted uranium and to understand its mechanism of interaction with humans including any possible harmful effects.
This conference has set the tone for further in-depth studies into the interaction of alpha-emitters with tissues and organisms for realistic dose assessments and to make internal dosimetry for radiation workers and the general public even more effective. It is hoped that there will be another occasion of this nature, e.g. a tenth international conference, to discuss this important topic again.
The Proceedings Editors of HEIR 2004

| Afting |
Dörr |
Hoel |
McGeoghegan |
Riddell |
Tschense |
| Aguado Casas |
Eckermann |
Hofmann |
Meinek |
Romanov |
Tschiersch |
| Atkinson |
Eisenmenger |
Hornhardt |
Miller |
Rosemann |
Urban |
| Balásházy |
Emmaneul |
Hornik |
Monchaux |
Roth |
Van Bladel |
| Bartusková |
Fattibene |
Huber |
Mori |
Rößler |
Van Kaick |
| Beck |
Flore |
Hurtgen |
Métivier |
Rühm |
Vocino |
| Becker |
Friedl |
Höllriegl |
Möhner |
Saigusa |
Wakeford |
| Bergs |
Friedland |
Ishikawa |
Müller |
Sasaki |
Walsh |
| Bertelli |
Fritsch |
Jacob |
Müller |
Schaffrath |
Wang |
| Bijwaard |
Fukumoto |
Johnson |
Müsch |
Rsoario |
Weiss |
| Boden |
Gerber |
Kiefer |
Nekolla |
Schirmer |
Wesch |
| Bouvier-Capely |
Gerdes |
Korschinek |
Newton |
Schlattl |
Wetzel |
| Burow |
Gerstmann |
Koukouliou |
Nikula |
Schmid |
Wick |
| Bussy |
Giussani |
Kreisheimer |
Noßke |
Schneider |
Wiedenhofer |
| Carlisle |
Goodhead |
Kreuzer |
Nuccetelli |
Schröder |
Wiethege |
| Chen |
Greiter |
Krieger |
Oeh |
Seidl |
Wörner |
| Cheng |
Grosche |
Lankenau |
Oestreicher |
Senekowitsch- Schmidtke |
Yann |
| Ciorba |
Gueguen |
Lassmann |
Paquet |
Speiss |
Zankl |
| Cordes |
Guilmette |
Laurier |
Paretzke |
Stather |
Weinmüller |
| Cosma |
Gössner |
Le Gall |
Pesch |
Stein |
Zaytsev |
| Cossonnet |
Hagen |
Leder |
Petitot |
Stephan |
|
| Coy |
Harder |
Li |
Petoussi-Henss |
Stradling |
|
| Danescu-Mayer |
Harrison |
Little |
Phipps |
Streffer |
|
| Dang |
Heeger |
Ludwig |
Priest |
Szoke |
|
| Dos Santos |
Heidenreich |
Lüder |
Pröhl |
Tapio |
|
| Silva |
Henrichs |
Machinami |
Rahola |
Taylor |
|
| Dublineau |
Henshaw |
Malatova |
Rateau-Matton |
Tomasek |
|
| Duffield |
Hermann |
Mallick |
Redlich |
|
|
|